ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury

ClinicalTrials.gov ID: NCT00597818

Public ClinicalTrials.gov record NCT00597818. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 1:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone for the Prevention of NSAID-induced Gastroduodenal Injury in Patients With Osteoarthritis and/or Rheumatoid Arthritis Patients

Study identification

NCT ID
NCT00597818
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sucampo Pharma Americas, LLC
Industry
Enrollment
121 participants

Conditions and interventions

Interventions

  • Cobiprostone Drug
  • Non-steroidal anti-inflammatory drug Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Mar 31, 2009
Completion
Apr 30, 2009
Last update posted
Dec 25, 2019

2007 – 2009

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Carl T Hayden VA Medical Center Phoenix Arizona 85012
Gregory J. Wiener, MD PC Chula Vista California 91910
Loma Linda University Physicians Medical Group Loma Linda California 92354
Facey Medical Foundation Mission Hills California 91345
Desert Oasis Healthcare Palm Springs California 92262
Sepulveda Ambulatory Care Center Sepulveda California 91343
University Clinical Research, Inc. Pembroke Pines Florida 33024
University of Illinois Medical Center Chicago Illinois 60612
Gulf Coast Research, LLC Baton Rouge Louisiana 70808
Boston Medical Center Boston Massachusetts 02118
Long Island Gastrointestinal Research Group Great Neck New York 11023
Research Associates of New York New York New York 10021
University of North Carolina Gastroenterology Chapel Hill North Carolina 27599
Oklahoma Founddation for Digestive Research Oklahoma City Oklahoma 73104
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Gastroenterology Section at Temple University Hospital Philadelphia Pennsylvania 19140
Dallas VA Research Corporation, Inc. Dallas Texas 75216
Houston Institute for Clinical Research Houston Texas 77074
Digestive and Liver Disease Specialists Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00597818, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2019 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00597818 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →